meRfi®-GM
Colitis-Associated Colorectal Cancer (CAC)
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Colitis-Associated Colorectal Cancer (CAC) is a specific type of colorectal cancer that develops in patients with inflammatory bowel disease (IBD), particularly ulcerative colitis (UC) and Crohn's disease (CD)
Yu 2018
Chattopadhyay et al. 2021 Applied Biochemistry and Biotechnology 193:1780-1799
Approx. 2% of Colorectal Cancer (CRC) is linked to pre-existing inflammation known as Colitis-Associated Colorectal Cancer (CAC), but most develops in pts without underlying [infla…
References (Sources)
- Blockade of IDO-kynurenine-AhR axis a rated colitis-associated colon cancer via inhibiting immune tolerance
- Genomic and molecular alterations in human inflammatory bowel disease-associated colorectal cancerReview
- Microbes and colorectal cancer: is there a relationship?
- miR-34a is a microRNA safeguard for Citrobacter-induced inflammatory colon oncogenesis
- Mucosa-associated microbiota dysbiosis in colitis associated cancer
- Novel regulatory roles of Wnt1 in infectionassociated colorectal cancer
- Roles of macrophages on ulcerative colitis and colitis-associated colorectal cancer